Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
69.40
-1.60 (-2.25%)
Nov 20, 2026, 5:25 PM CET
STO:IBT.B Market Cap
STO:IBT.B has a market cap or net worth of 934.92 million as of November 20, 2026. It is the 25,136th most valuable company in the world and the 309th biggest in Sweden. Its market cap has increased by 48.93% in one year.
Market Cap
934.92M
Enterprise Value
852.78M
Revenue
n/a
Global Rank
Country Rank
#309 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 29, 2016, STO:IBT.B's market cap has increased from 187.49M to 934.92M, an increase of 398.65%. That is a compound annual growth rate of 16.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 934.92M | 37.43% |
| Dec 30, 2025 | 680.31M | -5.78% |
| Dec 30, 2024 | 722.07M | -40.44% |
| Dec 29, 2023 | 1.21B | 116.00% |
| Dec 30, 2022 | 561.31M | -25.15% |
| Dec 30, 2021 | 749.91M | -40.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.55B |
| Genovis AB (publ.) | 1.53B |
| Flerie AB | 1.08B |
| AlzeCure Pharma AB | 783.26M |
| SynAct Pharma AB | 727.98M |
| Medivir AB | 651.64M |
| Oncopeptides AB | 648.27M |
| Xspray Pharma AB | 482.70M |